ABSTRACT Egg yolk phosvitin is one of the most phosphorylated proteins in nature, and the extraordinarily high concentration of phosphate groups in its structure provides a strong metal-binding ability. Phosvitin is known to possess various functional activities, including metal-chelating, antioxidant, emulsifying, antimicrobial, and cytotoxic activities. However, little is known about the immune-enhancing activity of phosvitin. The objective of this study was to evaluate the immune-enhancing activity of phosvitin in murine RAW 264.7 macrophages. Griess reagents and quantitative real-time PCR were used to determine the effect of phosvitin (at 12.5, 25, 50, and 100 μg/mL) on the levels of pro-inflammatory mediators NO and inducible nitric oxide synthase (iNOS), cytokines TNF-α and IL-1β in RAW 264.7 macrophages. The effect of phosvitin on the phagocytic activity of RAW 264.7 macrophages was also measured using the Neutral-Red Uptake method. Lipopolysaccharides was used as a positive control. Phosvitin significantly (P < 0.05) increased the production of NO in RAW 264.7 macrophages in a dose-dependent manner, but did not show any cytotoxicity. The amounts of NO produced were 3.47, 7.12, 10.23, and 14.57 μM in 12.5 to 100 μg/mL range of phosvitin (control: 0.46 μM). Compared with the untreated group, phosvitin treatment at a 100 μg/mL level increased the production of NO by 31.67 times. Phosvitin also significantly increased the mRNA expression of the RAW 264.7 macrophages: 100 μg/mL of phosvitin treatment increased the expression of mRNA for iNOS, TNF-α, and IL-1β by 46.25, 9.09, and 85.18 times of the control, respectively. The phagocytic activity of RAW 264.7 macrophages was also increased significantly by phosvitin treatment. These results demonstrated that phosvitin dramatically improved the immune functions RAW 264.7 macrophages by enhancing the production of immune mediators and increasing phagocytic activity. Therefore, phosvitin has a potential to be used as an immune-enhancing agent by food or nutraceutical industries.
INTRODUCTION
The stimulation of immune system is one of the important strategies to increase the human defense system, especially in the elderly and cancer patients because those people have an impaired immune response and a high susceptibility to infection (Salvioli et al., 2006) . In addition, with increasing age, the decline in immune function causes the reduction of vaccine efficacy (Aw et al., 2007) . The level of immune response can be controlled and maintained at an appropriate level by immunomodulatory materials C 2017 Poultry Science Association Inc. Received March 5, 2017. Accepted 0, 0000. 1 Corresponding authors: duahn@iastate.edu (DUA); hdpaik@konkuk.ac.kr (HDP) such as polysaccharides, protein, and some flavonoids (Castro et al., 2008; Jang et al., 2016; Qi et al., 2016; Li et al., 2017) . Therefore, activated natural killer cells and macrophages, which kill specific tumor cells, pathogens, and damaged cells, are very important for the elderly and cancer patients to boost their immune functions (Cameron and Churchill, 1980; Yamamura and Azuma, 1983) .
Macrophages perform several functions, which include host defense, inflammatory regulation, and tissue remodeling (Mosser and Edwards, 2008) . Macrophages play a vital role in both innate and adaptive immune response to pathogens through phagocytosis, antigen presentation, and cytokine secretion (Zhu et al., 2012) . Cytokines, such as tumor necrosis factor (TNF-α) and interleukin-1β (IL-1β), are important for proinflammatory reactions. They are also important for the 3872 host defense system because of their anti-bacterial, antiviral, and anti-tumor functions (Seo and Webster, 2002; van Horssen et al., 2006; Xia and Zhai, 2010; Li et al., 2016) . Macrophages also produce nitric oxide (NO) and prostaglandin E 2 (PGE 2 ) by regulating inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2), respectively. Nitric oxide and prostaglandin E 2 (PGE 2 ) are well known pro-inflammatory mediators. However, they can induce apoptosis or suppress the activities of immunoregulators (Xiong et al., 2014) . Therefore, searching for new materials that can boost immune function, such as the secretion of pro-inflammatory mediators or cytokines, became an important research topic in the immunopharmacology and cancer prevention fields (Seo et al., 2015) .
Egg yolk phosvitin is a highly phosphorylated protein with a molecular weight of 35 to 40 kDa, which is comprised of 10% phosphorus and 6.5% carbohydrates (Taborsky and Mok, 1967) . Phosvitin has a unique amino acid composition: it contains 123 serine residues, which account for 57.5% of the total amino acid residues, and almost all the serine is phosphorylated (Byrne et al., 1984) . This unique primary structure confers phosvitin with a very strong metal-chelating property and strong antioxidant activity (Lee et al., 2002; Castellani et al., 2004) . Phosvitin is also reported to have strong emulsifying, antimicrobial, melanogenesis inhibitory, cytotoxic, and antigenotoxic activities (Chung and Ferrier, 1992; Khan et al., 2000; Jung et al., 2012; Moon et al., 2014) . Despite having many desirable functional activities, there has been little study on the immune-enhancing activity of phosvitin. Various components from natural foods, such as polysaccharides from herb , proteins from ginseng (Qi et al., 2016) , and resveratrol from grapes (Castro et al., 2008) , were reported to have immune-enhancing activities. In this study, we investigated the immuneenhancing activity of phosvitin by measuring the production of NO and pro-inflammatory cytokines, and the phagocytosis ability of RAW 264.7 macrophages.
MATERIALS AND METHODS

Materials
Phosvitin was prepared from chicken egg yolk according to the method of Lee et al. (2014) . Briefly, egg yolk was separated from egg white, diluted with two volumes of cold (4 • C) distilled water, homogenized, and centrifuged. After removing the supernatant, the precipitant was homogenized with four volumes of 10% NaCl in 0.05 N NaOH solution to extract phosvitin. The pH of the homogenate was adjusted to 4.0 and then centrifuged to remove the precipitate. The supernatant was collected, heat treated at 70
• C for 30 min, and centrifuged to remove impurities. Salt was removed from the supernatant using ultrafiltration (Hollow fiber, 10-kDa cut-off-size, Flexstand, GE healthcare Bio-Sciences Corp., Piscataway, NJ), concentrated and then freezedried.
Dulbecco's modified Eagle's medium (DMEM) and fetal bovine serum were purchased from HyClone Laboratories, Inc. (Logan, MI). Penicillinstreptomycin was purchased from Gibco-BRL (Grand Island, NY) . N-(1-naphthyl)-ethylenediamine, sulfanilamide, 3-[4,5-dimethythiazol-2-yl]-2,5-diphenyl tetrazolium bromide, lipopolysaccharides (LPS), ammonium pyrrolidinedithiocarbamate (PDTC, NF-κB inhibitor), LY294002 (PI3K inhibitor), and SP600125 (MAPKs inhibitor) were obtained from Sigma-Aldrich Co. (St. Louis, MO). All other organic solvents and chemicals used were of analytical grades.
Cell Lines and Culture Conditions
RAW 264.7 murine macrophages were purchased from Korean Cell Line Bank (Seoul, Korea) and were cultured in DMEM supplemented with 10% fetal bovine serum, penicillin (100 U/mL), and streptomycin (100 μg/mL) at 37
• C in a humidified incubator containing 5% CO 2 (MCO-18AIC, SANYO, Osaka, Japan). The culture medium was replaced every 2 to 3 days.
Effects of Phosvitin on Cell Viability
Cell viability was measured using the 3-(4,5-dimethylthizol-2-yl)-2,5-diphenylatetetrazolium bromide (MTT) assay as described by Moon et al. (2013) . RAW 264.7 macrophages were transferred to a 96-well plate at a density of 2 × 10 5 cells/well, and treated with phosvitin (12.5, 25, 50, and 100 μg/mL). After 24 h, MTT (2.5 mg/mL in PBS) solution was added to each well and incubated for 4 h. The supernatant was removed and dimethylsulfoxide was added to dissolve the colored formazan crystals. The absorbance of the solution in the wells was determined at 570 nm using a microplate reader (Model 680, BioRad, Hercules, CA). Cell viability were calculated using the following equation:
Cell viability (%) = (absorbance of the sample/ absorbance of the control) × 100.
Effects of Phosvitin on the Production of Nitric Oxide (NO)
RAW 264.7 macrophages were incubated in a 96-well plate (2 × 10 5 cells/well) for 4 h. After incubation, macrophages were incubated again with phosvitin (12.5, 25, 50, and 100 μg/mL) or LPS (10 ng/mL) for 24 h. Under aerobic conditions, NO reacts with oxygen to produce nitrite, and the quantity was determined using Griess reagent (Chen et al., 2014) . Nitrite was measured by adding 100 μL of the Griess reagent (0.1% N-(1-naphthyl)-ethylenediamine dihydrochloride in distilled water and 1% sulfanilamide in 5% phosphoric acid) to 100 μL of supernatant for 15 min at room temperature. The absorbance was measured at 540 nm with a microplate reader and the concentrations of NO were calculated using the absorbance at 540 nm of standard solutions of sodium nitrate prepared in the culture medium.
Effects of Phosvitin on the Expression of Cytokine Levels
RAW 264.7 macrophages were incubated in a 6-well plate (1 × 10 6 cells/well) for 24 h, followed by another 24 h incubation with phosvitin (12.5, 25, 50, and 100 μg/mL) or LPS (10 ng/mL) treatment. Total RNA was isolated from macrophages using an RNeasy Mini Kit (Qiagen, Milan, Italy) according to the manufacturer's instructions and cDNA was synthesized using the Revert Aid First Strand cDNA Synthesis Kit (Thermo Fisher Scientific, Carlsbad, CA). The expression levels of cytokines from macrophages were determined by quantitative real-time PCR (qRT-PCR). The SYBR green kit (PhileKorea, Daejeon, Korea) was used and the sequences of primer of several cytokines used in this study are shown in Table 1 . Quantitative realtime PCR was performed according to the following protocol: 95
• C for 2 min (polymerase activation), 40 cycles of 95
• C for 5 s (denaturation), and 65
• C for 30 s (annealing/extension). The amplified results were analyzed using the delta-delta Ct method (β-Actin was used as the housekeeping gene) and the purity of PCR products was assessed by analyzing the melting curve.
Effects of Phosvitin on Phagocytic Activity
The phagocytic activity of RAW 264.7 macrophages was measured using the neutral red uptake method with some modifications . Briefly, the macrophages were incubated with phosvitin (12.5, 25, 50, and 100 μg/mL) or LPS (10 ng/mL) for 24 h, then the supernatant was removed. One hundred μL of neutral red solution (0.075% in PBS) was added to the plate and incubated for 30 min. The wells were washed three times with PBS and 100 μL of lysis buffer (ethanol: 0.01% glacial acetic acid = 1:1, (v/v)) was added. The absorbance of the solution in the wells was determined at 540 nm using a microplate reader.
Inhibition of NF-κB, Akt, and MAPKs using Specific Inhibitors
To confirm whether NF-κB, Akt, and MAPKs signaling pathways are involved in phosvitin-induced RAW 264.7 macrophages activation, macrophages were pretreated with specific NF-κB inhibitor, PDTC (20 μM), Akt (PI3K) inhibitor, LY294002 (10 μM), and MAPKs inhibitor, SP600125 (20 μM) dissolved in 1% DMSO for 4 h and further incubated for 24 h in the presence of phosvitin (100 μg/mL). The amounts of NO from supernatants were determined using the Griess reagent as described above.
Statistical Analysis
All results were presented as the means and the standard error. The experiments were performed in triplicates and the assays were repeated 3 times. Student t test was applied to measure significant differences in mean values. All calculations were performed using SPSS for Windows version 18.0 (SPSS Inc., Chicago, IL).
RESULTS AND DISCUSSION
Effects of Phosvitin on Cell Viability and NO and iNOS Secretion in RAW 264.7 Macrophages
Cell viability was measured using MTT assay. There was no significant induced cell death of RAW 264.7 macrophages between 12.5 to 100 μg/mL concentration range (Figure 1 ). To investigate whether phosvitin can activate macrophages, RAW 264.7 macrophages were treated with phosvitin (12.5 to 100 μg/mL) and incubated for 24 h. Figure 2 (a) indicated that phosvitin increased NO production in RAW 264.7 macrophages in a dose-dependent manner (P < 0.001). Compared with control (untreated group: 0.46 μM), phosvitin treatment increased the amounts of NO to 3.47 to 14.57 μM. The positive control (LPS, 10 ng/mL) showed 8.55 μM NO production. Phosvitin treatments showed strong immune-enhancing activities by potentiating NO production. Nitric oxide is a naturally occurring molecule that plays variety of roles in physiological process such as modulation of wound healing, vasodilation and neurogenesis, and acts as a modulator and an effector of the host innate immune response (Rizk et al., 2004; Wink et al., 2011) . Furthermore, NO helps kill virally infected cells, tumor cells, and some pathogens by inactivating their mitochondrial respiratory chain enzymes (MacMicking et al., 1997) . Nitric oxide is synthesized through the oxidative deamination of L-arginine by a family of nitric oxide synthase (NOS). The NOS are composed of three distinct isoforms, which include neuronal NOS, endothelial NOS, and inducible NOS (Dellamea et al., 2014) . Endothelial NOS is the main enzyme for producing NO under normal conditions, but iNOS is activated under certain clinical conditions as inflammation (Caimi et al., 2012) .
The effects of phosvitin on the secretion of iNOS mRNA are shown in Figure 2 (b) . Compared with the control (untreated group), phosvitin treatment at all concentration (P < 0.001) increased the secretion of iNOS mRNA. The level of iNOS mRNA in positive control (10 ng/mL LPS) was similar to that of the 50 μg/mL phosvitin treatment. This means that phosvitin increased the production of NO by stimulating the secretion of iNOS mRNA in RAW 264.7 macrophages. Many studies reported that natural compounds such as polysaccharides and proteins have immune-enhancing activity by activating macrophages (Cui et al., 2015; Li et al., 2016; Qi et al., 2016) . Cui et al. (2015) and Li et al. (2016) reported that polysaccharide from Radix Adenophorae (root of the Chinese perennial herbaceous plant) activated immune system by increasing the production of NO and the secretion of iNOS. Qi et al. (2016) studied a novel protein (AGNP) isolated from Panax quinquefolius L., which has immunostimulating effects, and found that the molecular weight of this protein was 31 kDa, which was similar to that of the phosvitin. AGNP dosedependently stimulated NO production through the upregulation of iNOS activity. , and then incubated with LPS (10 ng/mL) or phosvitin (12.5-100 μg/mL) for 24 h. The NO concentrations were measured by Griess method, and secretion of iNOS mRNA was measured using qRT-PCR. Values are expressed as the mean ± standard error of three replications.
* * * mean statistical difference for P < 0.001 (Student t test) compared with control. Control: untreated group, LPS: treated group with 10 ng/mL of LPS.
Effects of Phosvitin on Pro-Inflammatory Cytokines Expression in RAW 264.7 Macrophages
Quantitative real-time PCR analysis was performed to assess the effects of phosvitin on the expression of pro-inflammatory cytokines such as TNF-α and IL-1β. The results of qRT-PCR were shown in Figure 3 . Compared with control (untreated group), LPS (10 ng/mL) treatment increased the expression levels of TNF-α and IL-1β significantly (P < 0.001). Also, phosvitin increased the expression levels of TNF-α and IL-1β in a dose dependent manner. At 50 μg/mL phosvitin treatment the levels of TNF-α expression increased by 7.12-times compared with the control. This level was similar to that of the positive control (10 ng/mL LPS). The IL-1β expression also showed similar trends to TNF-α expression. Lipopolysaccharide (10 ng/mL) increased the IL-1β expression by 52.17-times, and phosvitin treatments (12.5, 25, 50, and 100 μg/mL) increased the IL-1β expression by 17.14-, 32.75-, 49.60-, and 85.18-times, respectively, compared to the control.
Many studies reported that the immune-enhancing materials increased the secretion or expression of Figure 3 . Effects of phosvitin on the secretion of pro-inflammatory cytokines TNF-α (a) and IL-1β (b) in RAW 264.7 macrophages. Cells were pre-incubated for 24 h, and then incubated with LPS (10 ng/mL) or phosvitin (12.5 to 100 μg/mL) for 24 h. The secretion of TNF-α and IL-1β mRNA was measured using qRT-PCR. Values are expressed as the mean ± standard error of three replications.
pro-inflammatory cytokines (TNF-α and IL-1β) (Wang et al., 2013; Ren et al., 2014; Sun et al., 2015; Li et al., 2016) . Wang et al. (2013) reported that the immunomodulatory activity of PBS extracts of G. amansii (red algae) was through enhancing the production of TNF-α and secretion of IL-1β. Moreover, several researchers reported that polysaccharides from various sources increased the expression of pro-inflammatory cytokines (Ren et al., 2014; Sun et al., 2015; Li et al., 2016) . Polysaccharides activated macrophages immune system by increasing the expression of pro-inflammatory cytokines. Macrophages actively participate in immune system by releasing TNF-α and IL-1β, which are pro-inflammatory cytokines. TNF-α is well known as an important pro-inflammatory cytokine participates in the host defense response. Tumor necrosis factor-α can stimulate innate immune response by activating macrophages and by inducing secretion of other inflammatory cytokines (Thieringer et al., 2000) . Interleukin-1β plays a key role in host immune response to infection because it has the ability to enhance phagocytic activity, which induces macrophage proliferation and promotes leukocyte migration (Dinarello, 1997) .
Phosvitin Enhanced the Phagocytic Activity of Macrophages
Phagocytosis is the characteristic feature of activated macrophages (Cheng et al., 2008) , which is the first and indispensable step in the response of macrophages to pathogens and cancer cells (Bai et al., 2012) . By measuring the uptake of neutral red (0.075%), the phagocytic activity of phosvitin was determined. As shown in Figure 4 , phosvitin significantly enhanced the phagocytic activity of RAW 264.7 macrophages in a dosedependent manner. Compared with control (untreated group), all concentrations of phosvitin increased the phagocytic activity of macrophages (P < 0.001). Moreover, the absorbance (540 nm) of samples with the phosvitin treatments (12.5 to 100 μg/mL) was greater than that with LPS treatment. The increase of phagocytic activity by phosvitin resulted in the enhancement of innate immune response against foreign materials, such as pathogens and tumor cells (Yu et al., 2013) . These results suggested that phosvitin activated the macrophages.
NF-κB, Akt, and MAPKs Signaling Pathways Participate in Phosvitin-Induced Macrophages Activation
When the pathways of NF-κB, Akt, and MAPKs were blocked by inhibitors, the amounts of NO induced by phosvitin in RAW 264.7 macrophages decreased . Effects of the specific inhibitors of NF-κB, Akt, and MAPKs on the phosvitin-induced production of NO in RAW 264.7 macrophages. , Vehicle: DMEM including 1% DMSO; , PSV: 100 μg/mL of phosvitin dissolved in DMEM. Cells were pre-incubated with specific inhibitors for 4 h, and further incubated with phosvitin (100 μg/mL) for 24 h. The NO concentrations were measured by Griess method. Values are expressed as the mean ± standard error of three replications.
### mean statistical difference for P < 0.001 (Student t test) compared with vehicle, * * * mean statistical difference for P < 0.001 compared with control. Control: untreated group.
( Figure 5 ), and the suppressing effect of inhibitors on NF-κB (PDTC), Akt (LY294002), and MAPKs (SP600125) was 45.09, 52.84, and 27.09%, respectively. These data clearly indicated that phosvitin-induced macrophage activation was mediated through the activation of NF-κB, Akt, and MAPKs pathways. These signaling pathways play important roles in regulating the synthesis and secretion of inflammatory mediators in RAW 264.7 macrophages (Coskun et al., 2011; Yan et al., 2016) .
In conclusion, the results obtained from this study indicated that phosvitin from hen egg yolk protein has immune-enhancing activity through the stimulation of pro-inflammatory mediator production. Phosvitin also increased the phagocytic activity of macrophages. Therefore, phosvitin should be considered as a potential immune-enhancing agent that can be used in foods or by nutraceutical industry. We have for the first time identified the immune-enhancing activity of phosvitin under normal cell conditions. However, further in vivo studies are needed before it can be applied to humans.
